Cartesian Therapeutics In... (RNAC)
undefined
undefined%
At close: undefined
18.68
0.08%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Net Income -219.71M 35.38M -25.69M -68.88M -55.35M -65.34M -65.32M -36.21M -25.17M -12.88M
Depreciation & Amortization 1.55M 1.29M 1.25M 734.00K 2.03M 975.00K 750.00K 802.00K 1.04M 864.00K
Stock-Based Compensation 22.52M 11.19M 7.72M 5.42M - - - - - 1.22M
Other Working Capital 1.23M -64.71M -45.50M 94.46M 1.12M -265.00K 9.30M 9.91M -87.00K -1.48M
Other Non-Cash Items 158.50M 2.29M 2.13M 1.75M 16.02M 8.45M 9.09M 830.00K 2.81M 193.00K
Deferred Income Tax -19.00M -21.40M 2.40M 10.85M - - - - - -
Change in Working Capital 4.97M -60.38M -48.19M 85.00M -4.48M -781.00K 7.12M 13.20M 427.00K -2.09M
Operating Cash Flow -51.16M -31.63M -60.38M 34.88M -51.44M -59.16M -52.04M -19.68M -22.46M -12.69M
Capital Expenditures -206.00K -1.20M -1.08M -815.00K -47.00K -884.00K -733.00K -586.00K -1.16M -227.00K
Acquisitions 6.56M - - 74.00K 122.00K 99.00K 4.00K 2.00K - -
Purchase of Investments - -33.50M -32.45M - -18.19M -15.60M -61.53M -28.42M - -
Sales Maturities Of Investments 28.25M 19.70M 16.40M - 18.34M 41.66M 60.16M - - -
Other Investing Acitivies - - - - - - - 6.90M -3.52M -
Investing Cash Flow 34.61M -15.00M -17.14M -741.00K 229.00K 25.27M -2.10M -22.10M -4.68M -227.00K
Debt Repayment -27.46M - - 5.42M -2.80M - 8.02M - 11.43M 4.49M
Common Stock Repurchased -6.17M - - - - - - - - -
Dividend Paid - - - - - - - - - -
Other Financial Acitivies 20.48M 235.00K 939.00K -3.37M 70.18M 697.00K 886.00K -3.95M 32.37M 20.28M
Financial Cash Flow -13.14M 39.22M 52.90M 14.43M 105.04M 697.00K 66.02M 67.66M 43.91M 24.77M
Net Cash Flow -29.75M -7.40M -24.63M 48.51M 52.77M -33.30M 11.96M 25.88M 16.76M 8.54M
Free Cash Flow -51.37M -32.83M -61.47M 34.07M -51.48M -60.05M -52.77M -20.27M -23.63M -12.91M